Dexamethason should be kept for serious Corona Virus Cases, WHO

zesham
0

LONDON. A cheap steroid dexamethasone that can help save the lives of patients with severe COVID-19 should be reserved for serious cases in which it has been shown to provide benefits, says World Health Organization Chief.

WHO chief Tedros Adhanom Ghebreyesus said research was at last providing “green shoots of hope” in treating the virus, which has killed more than 400,000 people worldwide and infected more than 8 million. 

Trial results announced on Tuesday by researchers in Britain showed dexamethasone, a generic drug used since the 1960s to reduce inflammation in diseases such as arthritis, cut death rates by around a third among the most severely ill coronavirus patients admitted to hospital. 

That makes it the first drug proved to save lives in fighting the disease. Countries are rushing to ensure that they have enough of it on hand, although medical officials say there is no shortage. 

Some doctors were cautious, citing possible side-effects and asking to see more data. 

A patient in Denmark received dexamethasone on Wednesday, local news agency Ritzau reported. 

The doctor who prescribed the drug said the medical profession was well acquainted with its side-effects. 

The head of the WHO’s emergencies programme, Mike Ryan, said the drug should only be used in those serious cases where it has been shown to help. 

“It is exceptionally important in this case, that the drug is reserved for use in severely ill and critical patients who can benefit from this drug clearly,” he told a briefing.

Post a Comment

0Comments

Post a Comment (0)

#buttons=(Ok, Go it!) #days=(20)

Our website uses cookies to enhance your experience. https://wikkipaki.blogspot.com/"Cookies Consent" href="/">Check Now
Ok, Go it!